Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

[1]  K. Kupferschmidt.  Big studies dim hopes for hydroxychloroquine. , 2020, Science.

[2]  Emily G McDonald,et al.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 , 2020, The New England journal of medicine.

[3]  J. Aronson,et al.  Chloroquine and hydroxychloroquine in covid-19 , 2020, BMJ.

[4]  Zhìhóng Hú,et al.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro , 2020, Cell Discovery.

[5]  Fumihiro Kato,et al.  Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells , 2020, Proceedings of the National Academy of Sciences.

[6]  Xu Liu,et al.  In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  X. de Lamballerie,et al.  Of chloroquine and COVID-19 , 2020, Antiviral Research.

[8]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[9]  Gengfu Xiao,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[10]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  Yukiko Shimizu,et al.  TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection , 2019, Journal of Virology.

[12]  B. Graham,et al.  Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization , 2018, Journal of Virology.

[13]  K. Shirato,et al.  Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry , 2017, Virology.

[14]  C. Ehrhardt,et al.  Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection , 2017, Scientific Reports.

[15]  K. Shirato,et al.  Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry , 2016, Journal of Virology.

[16]  S. Perlman,et al.  Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism , 2016, Proceedings of the National Academy of Sciences.

[17]  Yanchen Zhou,et al.  Protease inhibitors targeting coronavirus and filovirus entry , 2015, Antiviral Research.

[18]  G. Zimmer,et al.  A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon , 2011, PloS one.

[19]  M. Müller,et al.  Plaque assay for human coronavirus NL63 using human colon carcinoma cells , 2008, Virology journal.

[20]  D. Raoult,et al.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century , 2007, International Journal of Antimicrobial Agents.